Posted 8/31/2017 11:23 AM (GMT 0)
My understanding is that mongerson will be approved sometime in 2018, if all goes well. Otezla is harder to know because it's already been approved in other indications so it should be able to be approved faster with one or two major trials. That being said, they can take some time - I'd say likely next year also?